He Gang: Huawei Sports Health will support lung function, blood sugar, and high altitude health monitoring

IT House reported on June 14 that Huawei held a sports and health media communication meeting today. After the meeting, He Gang, chief operating officer of Huawei Terminal BG, tweeted that Huawei will focus on new research areas such as blood sugar, lung function, and altitude health management. Bring our users more comprehensive and intelligent health management.

He Gang said, “Behind the accurate health data monitoring of wearable products such as HUAWEI WATCH GT 3 Pro, HUAWEI WATCH D wrist ECG blood pressure recorder, and Huawei Band 7, there is a solid technical foundation. So far, HUAWEI TruSeen has been developed by itself. Technology research has been carried out for more than 7 years. It integrates the innovative technology and R&D strength of Huawei Sports Health Science Laboratory and Huawei Global Research Institute. From 1.0 to 5.0+, it has achieved innovative breakthroughs in hardware, algorithm, and process design. Accuracy continues to improve. In the future, our hardware, software and services will continue to improve. In addition to the continuous enhancement of basic detection capabilities such as heart rate, blood oxygen, and blood pressure,Huawei will bring our users more comprehensive and intelligent health management in the new research areas of blood sugar, lung function, and high altitude health management, to help everyone, every family, and every industry to enter the era of digital health management! “

IT House learned that the lung function health research is based on wearing heart rate, blood oxygen, breathing and audio signals to achieve lung function assessment and COPD screening, and predict the risk of acute exacerbation in advance. Plateau health research is based on the fusion of multi-modal parameters of wearable devices to achieve meter-less monitoring and high-reflection prediction, helping users to better plan their itineraries. Innovative blood sugar research is being jointly conducted with professional medical institutions in the industry, based on HUAWEI TruSeenT” technology and hardware monitoring capabilities, to achieve high blood sugar risk screening, trend assessment and early warning.